Dr. Preston S. Kerr, MD

Dr. Kerr practices at Baptist Hospitals of Southeast Texas in Beaumont, Texas, part of Community Hospital Corporation.

Dr. Kerr's NPI, 1265895957, was assigned on March 31, 2016. Dr. Kerr graduated from Oakland University William Beaumont School of Medicine in 2016. Dr. Kerr's New York license number on file is 309726.

Dr. Kerr's primary practice is Baptist Hospitals of Southeast Texas, at 3080 College Street, Beaumont, TX 77701 in Jefferson County. The practice phone is (409) 212-5000.

Dr. Kerr's primary practice is Baptist Hospitals of Southeast Texas in Beaumont, Texas, part of Community Hospital Corporation. Dr. Kerr is also affiliated with CHRISTUS Southeast Texas St. Elizabeth. The medical group on file is Baptist Hospitals of Southeast Texas.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kerr practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kerr's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kerr is board certified in urology by the American Board of Urology. Dmand AI has Dr. Kerr's licenses on file in 2 states: New York and Texas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Kerr treats.

CMS data shows 1,535 Medicare services from Dr. Kerr across 19 procedure codes in 2024, for 389 Medicare patients. Medicare paid $93,980 for them.

CMS counts 389 Medicare patients who saw Dr. Kerr in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kerr's median patient age at 69, with 24% women.

In 2024, Dr. Kerr wrote 2,677 Medicare Part D claims for 700 patients. 75% of them were for generic drugs. CMS names the drug for 2,563 of them, across 24 drugs with 11 or more claims each, at $409,446 in total drug cost. In 2023, CMS named 927 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kerr for performance year 2024, reported individually. Dr. Kerr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kerr as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Kerr, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Kerr, published from 2017 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Urethra, Urethral Stricture and Urinary Incontinence, Stress. Dr. Kerr has published most often in Case Rep Urol. Dr. Kerr's most frequent co-authors are Christopher David Kosarek, MD, Stephen Browning Williams, MD and Steven Benjamin Brandes, MD.

CMS Open Payments shows 78 general payments to Dr. Kerr from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $1,120.

Dr. Kerr graduated from Oakland University William Beaumont School of Medicine in 2016.

Dr. Kerr is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.